These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35150573)

  • 1. Approach to the Patient With Prader-Willi Syndrome.
    Höybye C; Tauber M
    J Clin Endocrinol Metab; 2022 May; 107(6):1698-1705. PubMed ID: 35150573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prader-Willi syndrome: an update on obesity and endocrine problems.
    Kim SJ; Cho SY; Jin DK
    Ann Pediatr Endocrinol Metab; 2021 Dec; 26(4):227-236. PubMed ID: 34991300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.
    Muscogiuri G; Formoso G; Pugliese G; Ruggeri RM; Scarano E; Colao A;
    Rev Endocr Metab Disord; 2019 Jun; 20(2):239-250. PubMed ID: 31065942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
    Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
    J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review.
    Napolitano L; Barone B; Morra S; Celentano G; La Rocca R; Capece M; Morgera V; Turco C; Caputo VF; Spena G; Romano L; De Luca L; Califano G; Collà Ruvolo C; Mangiapia F; Mirone V; Longo N; Creta M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA; Butler MG; Cataletto ME
    J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity management in Prader-Willi syndrome: current perspectives.
    Crinò A; Fintini D; Bocchini S; Grugni G
    Diabetes Metab Syndr Obes; 2018; 11():579-593. PubMed ID: 30323638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
    Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
    J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
    McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
    J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome.
    Dykens EM; Roof E; Hunt-Hawkins H
    Orphanet J Rare Dis; 2024 Feb; 19(1):83. PubMed ID: 38395848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prader-Willi syndrome: Hormone therapies.
    Tauber M; Diene G
    Handb Clin Neurol; 2021; 181():351-367. PubMed ID: 34238470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in genetic mechanisms of hypothalamic dysfunction in Prader-Willi syndrome.
    Wang XY; Sun R; Gao YQ
    Yi Chuan; 2022 Oct; 44(10):899-912. PubMed ID: 36384726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prader-Willi syndrome: endocrine manifestations and management.
    Alves C; Franco RR
    Arch Endocrinol Metab; 2020; 64(3):223-234. PubMed ID: 32555988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine manifestations and management of Prader-Willi syndrome.
    Emerick JE; Vogt KS
    Int J Pediatr Endocrinol; 2013 Aug; 2013(1):14. PubMed ID: 23962041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
    Griggs JL; Sinnayah P; Mathai ML
    Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation.
    Madeo SF; Zagaroli L; Vandelli S; Calcaterra V; Crinò A; De Sanctis L; Faienza MF; Fintini D; Guazzarotti L; Licenziati MR; Mozzillo E; Pajno R; Scarano E; Street ME; Wasniewska M; Bocchini S; Bucolo C; Buganza R; Chiarito M; Corica D; Di Candia F; Francavilla R; Fratangeli N; Improda N; Morabito LA; Mozzato C; Rossi V; Schiavariello C; Farello G; Iughetti L; Salpietro V; Salvatoni A; Giordano M; Grugni G; Delvecchio M
    Front Endocrinol (Lausanne); 2024; 15():1382583. PubMed ID: 38737552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychiatric aspects of Prader-Willi syndrome – a review].
    Briegel W
    Z Kinder Jugendpsychiatr Psychother; 2018 May; 46(3):238-246. PubMed ID: 28613110
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.